Cisplatin induced gamma-glutamyltransferase up-regulation, hypertrophy and differentiation in astrocytic glioma cells in culture

Histology and Histopathology

Volumn 18, Issue 3, 2003, Pages 687-693

  Mareš, Vladislav ^a   Lisa V ^a   Malik R ^a   Kozakova H ^b   Sedo A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

glutamyltranspeptidase; Astrocyte reactiveness; C6 glioma cells; Cellular stress; Cisplatin

Indexed keywords

CISPLATIN; GAMMA GLUTAMYLTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; BIOCHEMISTRY; CANCER CELL CULTURE; CELL CULTURE; CELL CULTURE MONITORING; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; GLIOMA CELL; HYPERTROPHY; MITOSIS INHIBITION; MORPHOLOGY; NONHUMAN; PROTEIN CONTENT; STAINING; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASTROCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; CISPLATIN; FLOW CYTOMETRY; GAMMA-GLUTAMYLTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; TIME FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA;

EID: 0037789550     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ashby L.S. and Shapiro W.R. (2001). Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: A phase II study. J Neurooncol., 51, 67-86.
2. Baliga R., Ueda N., Walker P.D. and Shah S.V. (1999). Oxidant mechanisms in toxic acute renal failure. Drug Metab. Rev. 31, 971-997.
3. Beppu T., Yoshida Y., Arai H., Wada T., Suzuki M., Ogawa A., Hakozaki S. and Kubo N. (2000). A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas. J. Neurooncol. 49, 213-218.
4. Berger W., Spiegl-Kreinecker S., Buchroithner J., Elbling L., Pirker C., Fischer J. and Micksche M. (2001). Overexpression of the human major vault protein in astrocytic brain tumor cells. Int. J. Cancer 94, 377-382.
5. Borud O., Mortensen B., Mikkelsen I.M., Leroy P., Wellman M. and Huseby N.E. (2000). Regulation of gamma-glutamyltransferase in cisplatin-resistant and -sensitive colon carcinoma cells after acute cisplatin and oxidative stress exposure. Int. J. Cancer 88, 464-468.
6. Castejon O.J., Castejon H.V., Diaz M. and Castellano A. (2001). Consecutive light microscopy, scanning-transmission electron microscopy and transmission electron microscopy of traumatic human brain oedema and ischaemic brain damage. Histol. Histopathol. 16, 1117-1134.
7. Chang W.K., Yang K.D. and Shaio M.F. (1999). Lymphocyte proliferation modulated by glutamine: Involved in the endogenous redox reaction. Clin. Exp. Immunol. 117, 482-488.
8. Cavenee W.K., Furnari F.B., Nagane M., Huang H.-J.S., Newcomb E.W., Bigner D.D., Weller M., Berens M.E., Plate K.H., Israel M.A., Noble M.D. and Kleihues P. (2000). Diffusely infiltrating astrocytomas. In: Tumors of the Nervous System. Pathology and Genetics. Kleihues P. and Cavenee W.K. (eds). IARC Press, Lyon. pp 10-21.
9. Daubeuf S., Leroy P., Paolicchi A., Pompella A., Wellman M., Galteau M.M. and Visvikis A. (2002). Enhanced resistance of HeLa cells to cisplatin by overexpression of gamma-glutamyltransferase. Biochem. Pharmacol. 64, 207-216.
10. Dringen R., Pfeifer B. and Hamprecht B. (1999). Synthesis of the antioxidant glutathione in neurons: Supply by astrocytes of CysGly as precursors for neuronal glutathione. J. Neurosci. 19, 562-569.
11. Godwin A.K., Meister A., O'Dwyer P.J., Huang C.S., Hamilton T.C. and Anderson M.E. (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA 89, 3070-3074.
12. Gordone J.A. and Gattone V.H. (1986). Mitochondrial alterations in cisplatin-induced acute renal failure. Am. Physiol. 250, 91-98.
13. Hanigan M.H. (1998a). Gamma-glutamyl transpeptidase, a glutathionase: It sexpression and function in carcinogenesis. Chem. Biol. Interact. 111-112, 333-342
14. Hanigan M.H., Frierson H.F. Jr. and Taylor P.T. Jr. (1998b). Expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy. Am. J. Obstet. Gynecol. 179, 363-377.
15. Hanigan M.H., Gallagher B.C., Townsend D.M. and Gabarra V. (1999). Gamma-glutamyltranspeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis, 20, 553-559.
16. Huang Z.Z., Chen C., Zeng Z., Yang H., Oh J., Chen L. and Lu S.C. (2001). Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver generation. FASEB. J. 15, 19-21.
17. Krajčí D., Mareš V., Lisá V., Španová A. and Vorlíček J. (2000). Ultrastructure of nuclei of cisplatin-treated C6 glioma cells undergoing apoptosis. Eur. J. Cell Biol. 79, 365-376.
18. Kruidering M., Van De Water B., De Heer E., Mulder G.J. and Nagelkerke J.F. (1997). Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: Mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J. Pharmacol. Exp. Ther. 280, 638-649.
19. Lojda Z. (1981). Proteinases in pathology. Usefulness of histochemical methods. J. Histochem. Cytochem. 29, 481-493.
20. Malík R., Mareš V., Kleibl Z., Pohlreich P., Vlačicová K. and Šedo A. (2001). Expression of attractin and its differential enzyme activity in glioma cells. Biochem. Biophys. Res. Commun. 284, 289-294.
21. Mareš V., Giordano P.A., Mazzini G., Lisá V., Pellicciari C., Scherini E., Bottiroli G. a nd Drobnik J. (1987). Influence of cis-dichlorodiammineplatinum on glioma cell morphology and cell cycle kinetics in tissue culture. Histochem. J. 19, 187-194.
22. Mareš V., Lisá V., Kozáková H., Marek J. and Tovaryš F. (2000). Gamma glutamyl-transpeptidase activity in biopsies of tumor and normal brain tissue. A histochemical and biochemical study. Pilsen Med. Fac. Proceedings, Suppl. 74, 269-270.
23. Markwell M.A., Haas S.M., Tolbert N.E. and Bieber L.L. (1981). Protein determination in membrane and lipoprotein samples: Manual and automated procedures. Methods Enzymol. 72, 296-303.
24. Meister A. (1982). Metabolism and function of glutathione: An overview. Biochem. Soc. Trans. 2, 78-79.
25. Mohri M., Nitta H. and Yamashita J. (2000). Expression of multidrug resistance-associated protein (MRP) in human gliomas. J. Neurooncol. 49, 105-115.
26. Morgenstern K., Hanson-Painton O., Wang BL. and De Bault L. (1992). Density-dependent regulation of cell surface gamma-glutamyl transpeptidase in cultured glial cells. Cell. Physiol. 150, 104-115.
27. Murray R.K. (2000). Metabolism of xenobiotics. In: Harper's Biochemistry. 25th. ed. Murray R.K., Granner D.K., Mayes P.A. and Rodwell V.W. (eds). Appleton and Lange. Stanford, Connecticut. USA. pp 780-786.
28. Necchi D., Scherini E. and Bernocchi G. (1997) Glial cell reaction to cis-dichloro-diammineplatinum treatment in the immature rat cerebellum. Exp. Neurol. 144, 219-226.
29. Paolicchi A., Pompella A., Tonarelli P., Gadducci A., Genazzani A.R., Zunino F., Pratesi G. and Tongiani R. (1996). Gamma-glutamyltranspeptidase activity in human ovarian carcinoma. Anticancer Res. 16, 3053-3058.
30. Schafer C., Fels C., Brucke M., Holzhausen H.J., Bahn H., Wellman M., Viskivis A., Fischer P. and Rainow N.G. (2001). Gamma-glutamyltransferase expression in higher-grade astrocytic glioma. Acta Oncol. 40, 529-535.
31. Schnelldorfer T., Gansauge S., Gansauge F., Schlosser S., Beger HG. and Nussler A.K. (2000). Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89, 1440-1447.
32. Sulakhe S.J. (1987). Gamma-glutamyltranspeptidase in methyl-benz[a]anthracene-induced mammary adenocarcinomas and in livers of tumor bearing rats. Int. J. Biochem. 6, 509-515.
33. Townsend D.M. and Hanigan M.H. (2002). Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J. Pharmacol. Exp. Therap. 300, 142-148
34. Vinores S.A., Derevjanik N.L., Shi A., Vinores A., Klein D.A. and Whittum-Hudson J.A. (2001). Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF beta), and interleukin-6 (IL-6) in experimental herpes virus retinopathy: Association with inflammation and viral infection. Histol. Histopathol. 16, 1061-1071.
35. Zhang K., Chew M., Yang E.B., Wong K.P. and Mack P. (2001). Modulation of cisplatin cytotoxicity and cisplatin-induced DNA crosslinks in HeG2 cells by regulation of glutathione-related mechanisms. Mol. Pharmacol. 59, 837-843.